Cartesian Therapeutics announces FDA agreement for new trial

28th January 2025 Uncategorised 0

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25

More: Cartesian Therapeutics announces FDA agreement for new trial
Source: News